Interestingly, Bi, et al.24(2018) suggest that the combination of RA and BMP2/7 could be a novel approach to treat hyperactive osteoclast-induced bone loss such as in inflammation-induced severe osteoporosis and bone loss caused by cancer metastasis to bone. The gene discussed is BMP2; the disease is cancer.